secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTUITIVE SURGICAL INC (ISRG)
CIK:        0001035267
Form:       8-K
Filed at:   2026-07-16T20:05:17+00:00
Accession:  0001035267-26-000047
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Intuitive Surgical Q2 revenue $2.89B (+19% YoY); GAAP EPS $2.29, non-GAAP $2.80
-------------------------------------------------------------------------------

- Worldwide procedures grew ~16% (da Vinci +15%, Ion +36%); 468 da Vinci systems placed (246 da Vinci 5).
- GAAP net income $818M ($2.29/diluted share) vs $658M ($1.81) YoY; non-GAAP net income $1.00B ($2.80).
- Q2 included $28M net benefit from IEEPA tariff refunds; repurchased 0.9M shares for $0.38B.
- FY2026 guidance: da Vinci procedure growth ~13.5%-15.5% (closer to midpoint); non-GAAP gross margin 68%-69%.
- Non-GAAP operating expense growth guided at 11%-13%; tariff impact estimated at 1% of revenue.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1035267/000103526726000047/0001035267-26-000047-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1035267/000103526726000047/isrg-20260716.htm
  HTML page:      https://secwatch.observer/filing/0001035267-26-000047

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer